Biological Diversity by Design
Seres Therapeutics has built a proprietary discovery and design platform that enables us to understand the dysbiosis associated with specific diseases.
More
Product Pipeline
We are developing a novel class of biological drugs designed to treat disease by restoring the function of a dysbiotic microbiome.
More
Clinical Trials
We have multiple active clinical studies to evaluate our microbiome therapy clinical candidates.
More